In vivo evaluation of tigemonam, a novel oral monobactam.
Tigemonam, a new monobactam with excellent activity against gram-negative bacteria, was evaluated for in vivo efficacy and absorption after oral administration to laboratory animals. Tigemonam is absorbed when administered orally to mice and dogs. In a variety of gram-negative systemic infections in...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1987
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174696/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3551830/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.2.226 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|